Aeolus Pharmaceuticals Inc. Reports Consolidated Unaudited Earnings Results for the Second Quarter and Six Months Ended March 31, 2015
For the six months, the company reported contract revenue of $2,114,000 compared with $2,231,000 for the same period last year. Loss from operations was $1,410,000 compared with $1,132,000 for the same period last year. Net loss was $1,410,000 or $0.01 diluted per share compared with $1,132,000 or $0.01 diluted per share for the same period last year. Net cash used in operating activities was $1,269,000 compared with $349,000 for the same period last year.